Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$70,521,132
+$23,438,720 QoQ
Shares Held
827,810
+15.9% QoQ
Ownership
0.595%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#41
of 480 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. CYTK ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
827,810 | $70,521,132 |
All Filings in CYTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,521,132 | 827,810 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $47,082,412 | 714,344 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $52,602,414 | 827,863 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $43,143,599 | 785,000 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $22,344,290 | 676,280 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $20,997,988 | 522,468 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $23,019,588 | 489,362 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17,322,201 | 328,072 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $20,807,394 | 384,042 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $24,853,853 | 354,498 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $38,996,341 | 467,078 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $18,161,441 | 616,478 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,001,123 | 429,219 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $19,873,622 | 564,752 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $27,471,013 | 599,542 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $30,465,311 | 628,799 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $25,676,525 | 653,513 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $29,196,072 | 793,156 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $38,314,593 | 840,601 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $29,369,237 | 821,747 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $21,685,961 | 1,095,804 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $21,090,353 | 906,722 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $13,197,087 | 635,086 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||